Author Correction: Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. [PDF]
Wang H +13 more
europepmc +1 more source
Daridorexant‐ Case Report of Possible Side‐Effect in Rare Mitochondrial Disorder
ABSTRACT This case report describes a 40‐year‐old woman with maternally inherited diabetes and deafness (MIDD), a rare mitochondrial disorder, who received treatment with daridorexant due to severe chronic insomnia. She developed progression of her MIDD symptoms during treatment.
Sven Svedmyr, Joel Bergqvist
wiley +1 more source
TRIM47, stabilized by YTHDF3-mediated m6A modification, promotes cardiac lipid accumulation and aggravates diabetic cardiomyopathy. [PDF]
Wang W +6 more
europepmc +1 more source
Selenium Levels in Brazil Nuts: A Global Review of the Literature
ABSTRACT Brazil nuts (BN, Bertholletia excelsa, Lecythidaceae) are frequently recommended for increasing selenium intake. Many individuals residing in regions with low soil selenium values, particularly including vegetarians, have selenium intakes below the dietary reference values. A literature review of selenium levels in BN was conducted to estimate
Christian Koeder +2 more
wiley +1 more source
Advanced glycation end products and RAGE signaling in diabetic cardiomyopathy: distinct mechanisms, human evidence, and translational barriers. [PDF]
Wang Z, Shi Q, Li X, Zhang Z, Li M.
europepmc +1 more source
ABSTRACT Introduction Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking.
Muhammed Rashid +6 more
wiley +1 more source
Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial. [PDF]
Batista JL +13 more
europepmc +1 more source
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed +19 more
wiley +1 more source
Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy. [PDF]
Su N +5 more
europepmc +1 more source

